Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00617786 · ClinicalTrials.gov registry record · NA
CPT Testing for Sacral Neuromodulation Outcomes
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00617786: Completed NA study, sponsored by Corewell Health East.
NCT00617786 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00617786, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is a prospective study. Subjects will be recruited from the urology practices of Dr. Ken Peters and Dr. Ananias Diokno at William Beaumont Hospital. Subjects will be referred to the study by the clinician recommending Sacral NeuroModulation therapy (SNM). This pilot study is to explore the effect of SNM on sensory pathways by measuring CPT values pre and post SNM treatment.
Interventions
- PROCEDURE Current Perception Threshold (CPT) Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-07 |
| Phase | NA |
What the finished NCT00617786 record still lists
NCT00617786 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Current Perception Threshold (CPT) Testing is the first listed.
NCT00617786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00617786 about?
NCT00617786 is a clinical study titled "CPT Testing for Sacral Neuromodulation Outcomes". This is a prospective study. Subjects will be recruited from the urology practices of Dr. Ken Peters and Dr. Ananias Diokno at William Beaumont Hospital. Subjects will be referred to the study by the clinician recommending Sacral NeuroModulation therapy (SNM). This pilot study is to explore the eff...
What is the current status of trial NCT00617786?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2008-10. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00617786?
The interventions under investigation include: Current Perception Threshold (CPT) Testing (PROCEDURE).
Who is sponsoring clinical trial NCT00617786?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00617786's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia